FitLife Brands Q4 2024: Navigating Supply Chain Challenges and Future Revenue Hurdles
Generated by AI AgentAinvest Earnings Call Digest
Thursday, Mar 27, 2025 8:13 pm ET1min read
FTLF--
These are the key contradictions discussed in FitLife Brands' latest 2024Q4 earnings call, specifically including: Supply Chain and Tariff Issues, and Future Revenue Expectations:
Revenue and Growth:
- FitLife Brands reported total revenue of $64.5 million for the full year 2024, an increase of 22% year-over-year.
- The growth was primarily driven by a 29% increase in online sales and benefited from the integration and optimization of acquired brands.
Legacy FitLife Performance:
- Legacy FitLife revenue for Q4 2024 was $5.3 million, declining 13% overall, with a 1% decline in online sales.
- The decline was due to a commercial dispute with GNC, leading to a halt in orders andDirect fulfillment to franchisees.
MusclePharm Brand Growth:
- MusclePharm's revenue increased 14% sequentially in Q4 2024, driven by a 37% increase in wholesale revenue.
- Growth was attributed to increased promotional investments and new product launches under the MusclePharm Pro Series.
Mimi's Rock (MRC) Brands Performance:
- MRC revenue for Q4 2024 was $6.9 million, down slightly 0.4% from the previous year.
- Challenges in the skin care brands and a revenue optimization process led to a decline, but contributed as a percentage of revenue increased from 28.2% to 37.1%.
Revenue and Growth:
- FitLife Brands reported total revenue of $64.5 million for the full year 2024, an increase of 22% year-over-year.
- The growth was primarily driven by a 29% increase in online sales and benefited from the integration and optimization of acquired brands.
Legacy FitLife Performance:
- Legacy FitLife revenue for Q4 2024 was $5.3 million, declining 13% overall, with a 1% decline in online sales.
- The decline was due to a commercial dispute with GNC, leading to a halt in orders andDirect fulfillment to franchisees.
MusclePharm Brand Growth:
- MusclePharm's revenue increased 14% sequentially in Q4 2024, driven by a 37% increase in wholesale revenue.
- Growth was attributed to increased promotional investments and new product launches under the MusclePharm Pro Series.
Mimi's Rock (MRC) Brands Performance:
- MRC revenue for Q4 2024 was $6.9 million, down slightly 0.4% from the previous year.
- Challenges in the skin care brands and a revenue optimization process led to a decline, but contributed as a percentage of revenue increased from 28.2% to 37.1%.
Descubre qué cosas los ejecutivos no quieren revelar durante las llamadas de conferencia.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet